ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "A Feast Of Updates"
Episode Synopsis
Lots of recent clinical trial updates to discuss:
AQUILA: Daratumumab for high-risk smoldering multiple myeloma
Checkmate 8HW: Nivo/Ipi for MSI-high/MMRd metastatic colorectal cancer
DESTINY-Breast06: T-DXd in HER2-low MBC after hormonal treatment, but without previous chemo for MBC
ARMANI: Switch maintenance ramucirumab-paclitaxel in metastatic gastric/GEJ cancer
HELEN-006: Neoadjuvant nab-paclitaxel/trastuzumab/pertuzumab vs. TCHP in breast cancer
SONIA: finally published!
AQUILA: Daratumumab for high-risk smoldering multiple myeloma
Checkmate 8HW: Nivo/Ipi for MSI-high/MMRd metastatic colorectal cancer
DESTINY-Breast06: T-DXd in HER2-low MBC after hormonal treatment, but without previous chemo for MBC
ARMANI: Switch maintenance ramucirumab-paclitaxel in metastatic gastric/GEJ cancer
HELEN-006: Neoadjuvant nab-paclitaxel/trastuzumab/pertuzumab vs. TCHP in breast cancer
SONIA: finally published!
More episodes of the podcast OncoPharm
Bladder Cancer Updates & SC Amivantamab
18/12/2025
ASH 2025
11/12/2025
DPYD Deficiency Testing
04/12/2025
Cornucopia of Autumn Updates
26/11/2025
PGYNone: Dandelion Effect
20/11/2025
PGY1 Pathway: Road Trip!
13/11/2025
PGY2 Pathway: A Planned City
06/11/2025
Tale from the Crypt: Belantamab Mafodotin
30/10/2025
ESMO 2025
23/10/2025
IL-2
16/10/2025
In God we trust